Counselors in Hastings On Hudson, NY Accepting Medicare

8 Counselors found. Showing 1 - 8

Ms. Chrystal Renee Allen, LMHC, NCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 78 Main St, Hastings On Hudson, NY 10706 Phone: 914-274-8334

Joann M Streany, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1 S Broadway, Hastings On Hudson, NY 10706 Phone: 845-232-0388

Tamsin Laura Taylor, PG DIP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 603 Warburton Ave, Hastings On Hudson, NY 10706 Phone: 917-391-4340

Ms. Karen Shulman, R027119-1 Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 33 Washington Ave, Hastings On Hudson, NY 10706 Phone: 914-478-5522

Stephanie Barbara Buck, M.P.S. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1 North St, Hastings On Hudson, NY 10706 Phone: 914-478-4200

Lindsay I March, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 78 Main St, Hastings On Hudson, NY 10706 Phone: 914-274-8334

Mrs. Genevieve Morciglio Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Cedar St, Hastings On Hudson, NY 10706 Phone: 914-231-6514

Ms. Cheryl A Rothberg, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 50 Farragut Ave, Hastings On Hudson, NY 10706 Phone: 914-552-6680    Fax: 914-231-6513

News Archive

Faster diagnosis of early-stage Alzheimer's disease

Research by faculty and staff at Rowan University, Glassboro, N.J.; the University of Pennsylvania School of Medicine; and Drexel University may lead to better diagnosis of early-stage Alzheimer's disease.

ERYTECH partners with Queen's University to advance its product candidate for treating arginase-1 deficiency

ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.

Elevated oral pathogens, less bacterial diversity linked to risk of developing precancerous gastric lesions

Elevated pathogen colonization and a lack of bacterial diversity in the mouth were identified in people with precancerous lesions that could precede stomach cancer, finds a new study led by New York University College of Dentistry and New York University School of Medicine.

Read more Medical News

› Verified 4 days ago